Jiaqi Tan

Responses to Dasatinib as a Second- and Third-Line Tyrosine Kinase Inhibitor in Chronic Phase Chronic Myeloid Leukaemia Patients

J. Cen, Qinrong Wang, Jinlan Pan, 2019, Acta Haematologica.

Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy

Jianfeng Zhou, D. Kuang, Liting Chen, 2020, Medicine.